TB Alliance, Pharmaceutical Partner Begin Clinical Trial For XDR-TB Treatment Regimen In South Africa

Center for Global Health Policy’s “Science Speaks”: First all-oral XDR-TB drug regimen trial launches in South Africa
Rabita Aziz, policy research coordinator for the Center for Global Health Policy, discusses the start of a TB treatment clinical trial in South Africa, writing, “The TB Alliance Wednesday announced the launch of the first clinical trial testing an all-oral regimen to treat extensively drug-resistant tuberculosis. With a three drug combination, the Nix-TB regimen trial seeks to cure patients within six to nine months…” (5/14).